Allogeneic Anti-CD19 CAR T Cells Manufactured from Healthy Donors Provide a Unique Cellular Product with Distinct Phenotypic Characteristics Compared to CAR T Cells Generated from Patients with Mature B Cell Malignancies (2019)
Attributed to:
Large scale lentiviral vector production
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood-2019-123018
Publication URI: http://dx.doi.org/10.1182/blood-2019-123018
Type: Journal Article/Review
Parent Publication: Blood
Issue: Supplement_1